Fransen Heidi P, de Jong Nynke, Wolfs Marion, Verhagen Hans, Verschuren W M Monique, Lütjohann Dieter, von Bergmann Klaus, Plat Jogchum, Mensink Ronald P
National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, the Netherlands.
J Nutr. 2007 May;137(5):1301-6. doi: 10.1093/jn/137.5.1301.
The consumption of products enriched with plant sterol or stanol esters lowers serum total and LDL-cholesterol concentrations, thereby most likely reducing the risk of coronary heart disease. However, using plant sterol (not plant stanol) enriched products elevates serum plant sterol concentrations in humans. This may be unwanted because health effects of elevated serum plant sterol concentrations are still controversial. Within postlaunch monitoring of functional foods, we compared serum plant sterol and plant stanol concentrations among users of plant sterol (n = 67) or plant stanol (n = 13) enriched margarines with those of matched nonusers (n = 81) in the ongoing Dutch Doetinchem cohort study. Subjects (aged 29-67 y) were examined in 1994-1998 (before the introduction of enriched margarines) and re-examined in 1999-2003. Serum concentrations of plant sterols and stanols were measured in samples from nonfasting subjects by GLC-MS. Intake of plant sterols was 1.1 +/- 0.6 g/d and was associated with a decrease of serum total cholesterol concentration of 0.25 +/- 0.91 mmol/L (4%, P < 0.05), a change that differed (P < 0.05) from the nonsignificant increase in nonusers (+2%, 0.12 +/- 0.78 mmol/L, P = 0.16). Cholesterol-standardized serum sitosterol and campesterol increased in plant sterol users by 22% (P < 0.0001) and 103% (P < 0.0001), respectively. Cholesterol-standardized serum sitostanol and campestanol increased in plant stanol users by 197% (P = 0.02) and 196% (P = 0.01). To our knowledge, these data are the first to show changes in serum cholesterol, plant sterol, and plant stanol concentrations after (long-term) consumption of plant sterol and stanol enriched margarines in a free-living population in a nonexperimental setting. Whether the increased serum sterol concentrations result in adverse side effects needs to be investigated in future postlaunch monitoring studies.
食用富含植物甾醇或甾烷醇酯的产品可降低血清总胆固醇和低密度脂蛋白胆固醇浓度,从而极有可能降低冠心病风险。然而,食用富含植物甾醇(而非植物甾烷醇)的产品会提高人体血清植物甾醇浓度。这可能并非所愿,因为血清植物甾醇浓度升高对健康的影响仍存在争议。在对功能性食品上市后监测中,我们在荷兰多廷赫姆队列研究中,比较了食用富含植物甾醇(n = 67)或植物甾烷醇(n = 13)人造黄油的人群与匹配的未食用者(n = 81)的血清植物甾醇和植物甾烷醇浓度。研究对象(年龄29 - 67岁)于1994 - 1998年(富含植物甾醇人造黄油引入之前)接受检查,并于1999 - 2003年再次接受检查。通过气相色谱 - 质谱联用仪(GLC - MS)测量非空腹受试者样本中的植物甾醇和甾烷醇血清浓度。植物甾醇摄入量为1.1±0.6克/天,与血清总胆固醇浓度降低0.25±0.91毫摩尔/升(4%,P < 0.05)相关,这一变化与未食用者的无显著升高(+2%,0.12±0.78毫摩尔/升,P = 0.16)不同(P < 0.05)。植物甾醇食用者中胆固醇标准化血清谷甾醇和菜油甾醇分别升高了22%(P < 0.0001)和103%(P < 0.0001)。植物甾烷醇食用者中胆固醇标准化血清谷甾烷醇和菜油甾烷醇分别升高了197%(P = 0.02)和196%(P = 0.01)。据我们所知,这些数据首次表明在非实验环境下自由生活人群长期食用富含植物甾醇和植物甾烷醇的人造黄油后血清胆固醇、植物甾醇和植物甾烷醇浓度的变化。血清甾醇浓度升高是否会导致不良副作用需要在未来的上市后监测研究中进行调查。